Nasdaq Inc Stock Price, News & Analysis

On January 12, 2021, Nasdaq (NDAQ) released its monthly and quarterly volume reports for December 2020. The report highlighted record trading volumes in specific asset classes and the highest number of IPOs in decades, resulting in better-than-expected revenues for Q4 2020. However, incremental expenses of $20 million were noted due to performance-linked compensation. Additionally, a single customer project was projected to incur $25 million in losses over 13 years, leading to an increase in non-GAAP operating expenses by approximately $45 million above previous guidance.

Nasdaq announced that it led all exchanges in total equity options trading volume for 2020, marking its 11th consecutive year at the forefront. With 365 million trades and 2.58 billion contracts processed, this represented a 52% increase over 2019, making it the most active year since options became tradeable in 1973. The spike in options trading was largely attributed to volatility surrounding the U.S. elections and COVID-19, which increased retail participation. Nasdaq's technology enhanced price discovery and risk transfer for investors.

Nasdaq (NDAQ) will announce its Fourth Quarter 2020 financial results on January 27, 2021, at 8:00 AM Eastern. The announcement will be accompanied by a conference call featuring Nasdaq's CEO, CFO, and senior management. Participants can access the call via the Nasdaq Investor Relations website. An audio replay will be available afterward. The press release will be published on the Investor Relations website earlier that day at approximately 7:00 AM Eastern. This event offers insights into Nasdaq's latest financial performance and strategic direction.

In 2020, Nasdaq (NDAQ) led the U.S. exchange market by welcoming 300 IPOs, raising a total of $77.86 billion, marking its largest IPO year in the past decade. With an 83% success rate for operating companies, Nasdaq also attracted 21 firms switching from the NYSE, representing $278 billion in market value. Significant IPOs included Airbnb and Warner Music Group. Nasdaq's initiatives to modernize SEC rules further underscore its commitment to enhancing market integrity. The exchange continues to dominate sectors like Health Care and Technology, achieving impressive win rates in venture and private equity-backed listings.

Nasdaq (Nasdaq: NDAQ) will implement its annual reconstitution of the Nasdaq-100 Index® on December 21, 2020. Six companies will join the index, including American Electric Power Company, Marvell Technology Group, and Peloton Interactive. The reconstitution process involves adding and removing companies based on market capitalization, with the new additions replacing companies like BioMarin Pharmaceutical and Take-Two Interactive. The Nasdaq-100 Index serves as a benchmark for various financial products and is crucial for market performance tracking.

On December 11, 2020, Nasdaq (NDAQ) announced the reconstitution of the Nasdaq Biotechnology Index (NBI), effective December 21, 2020. This annual adjustment will include 100 new biotech and pharmaceutical securities, enhancing the index's representation in the sector. Notable additions are Arbutus Biopharma, Adaptimmune Therapeutics, and BioNTech, among others. Conversely, 16 securities will be removed from the index, including ADMA Biologics and Myris, Inc. The changes aim to better reflect market trends and advance investor insights into the biotech landscape.